Virology News and Research

Latest Virology News and Research

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has announced the completion of enrollment in its Phase IIb imm01 clinical trial of V5 in tuberculosis.

15 Nov 2010

U.N. agencies, Rotary International launch mass polio immunization campaign in Central Africa

The WHO, UNICEF and Rotary International on Thursday announced they will kick off a "mass polio immunization campaign in three Central African nations" on Friday "in response to a polio outbreak suspected in more than 100 deaths and deemed 'unusual' because it targets adults more than children," the Associated Press reports.

14 Nov 2010

Australian epidemics research programme to be disbanded

The Australian Federal Government scrapped the funding to the Australian National University’s Master of Applied Epidemiology (MAE) program. This group helps Australia’s response to major disease outbreak and will be disbanded at the end of next year. According to Emeritus Professor Robert Douglas who founded this program, this has been responsible for Australia’s response to serious epidemic outbreaks in the past.

14 Nov 2010

Scientists to present new findings from NIAID-funded research at ACAAI Annual Meeting

The 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) brings together leading allergists and immunologists from around the world.

12 Nov 2010

Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada

Forest Laboratories, Inc. announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered into a definitive collaboration and distribution agreement for Bystolic® (nebivolol) and Savella® (milnacipran HCl) in Canada with Janssen Pharmaceutica, NV and Janssen Pharmaceutical respectively, on behalf of Janssen Inc., which will market the products in Canada.

12 Nov 2010

Stanford University scientist receives HFSP Nakasone Award for neuronal network study

The first HFSP Nakasone Award has been conferred upon Karl Deisseroth of Stanford University for his pioneering work on the development of optogenetic methods for studying the function of neuronal networks underlying behavior.

12 Nov 2010

SCYNEXIS receives four grants under QTDP program to develop cyclophilin inhibitors

Drug discovery and development company SCYNEXIS, Inc. today announced that the Company has been awarded four grants totaling $977,917 under the U.S. Federal Government's Qualifying Therapeutic Discovery Project (QTDP). SCYNEXIS is developing a proprietary internal pipeline of cyclophilin inhibitors, a class of drugs that hold significant potential for the treatment of a broad range of diseases.

11 Nov 2010

Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications

Roche Diagnostics and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.

From Roche Sequencing and Life Science 11 Nov 2010

New study sheds light on Immune Reconstitution Inflammatory Syndrome

Newly published research by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, sheds light on a poorly understood, acute illness called Immune Reconstitution Inflammatory Syndrome (IRIS) that develops in some HIV-infected individuals soon after they begin antiretroviral therapy.

11 Nov 2010

Combination of antiviral drugs outperforms single-drug therapy in children with hepatitis C

Children with hepatitis C fare decidedly better with a supercharged combination of two antiviral drugs than with the usual and standard single-drug regimen, according to research led by investigators at the Johns Hopkins Children Center.

11 Nov 2010

Kylin receives $250,000 IRS award to advance pRNAi nanoparticle cancer treatment research

Officials of Kylin Therapeutics Inc. announces that they received a therapeutic discovery project grant from the U.S. Internal Revenue Service that will advance the company's pRNAi nanoparticle cancer treatment research.

11 Nov 2010

Researchers find text messages to HIV patients improve adherence, health outcomes in Kenya trial

Using mobile-phone text messages to remind HIV patients to take their dose of life-saving medications can give a major boost to drug adherence, according to an innovative trial in Kenya unveiled on Tuesday, Agence France-Presse reports.

10 Nov 2010

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.

10 Nov 2010

HPV vaccination rates falter

According to the latest research lesser numbers of teenage girls and young women are getting infected by the human papillomavirus vaccine (HPV) – a virus linked to cervical cancer. Research also shows that most who start the vaccination regimen against the virus fail to take all three doses.

10 Nov 2010

Contraceptive, antiviral gel using bee venom wins 2010 Gates Foundation grant

A vaginal gel that affords both contraception and HIV protection using nanoparticles that carry bee venom is one of the bold, unconventional ideas that won a 2010 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.

10 Nov 2010

World Lung Foundation report highlights prevalence of acute respiratory infections worldwide

Acute respiratory infections (ARIs) - such as influenza, pneumonia and respiratory syncytial virus (RSV) - cause 4.25 million deaths each year often among young children in developing countries, according to the Acute Respiratory Infections Atlas, which was released on Tuesday by the World Lung Foundation, Reuters reports (11/9).

10 Nov 2010

New York Times examines HIV prevention products undergoing clinical trials

The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."

10 Nov 2010

Patented cover for stethoscopes will curb hospital-acquired infections

Saints Medical Center is pleased to announce that Richard H. Ma, M.D, chair of its hospitalist department, has received a patent for a lightweight plastic cover for stethoscopes that will dramatically reduce hospital-acquired infections.

9 Nov 2010

Innovative method for in-cell gene manipulation

A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU), Tainan, Taiwan, has announced a breakthrough in the precision in-cell gene scission at pre-designed sequence sites using Artificial Targeting Light Activated Nano Scissors (ATLANS) and a custom build photonic device.

9 Nov 2010

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

9 Nov 2010

Virology News and Research

Latest Virology News and Research

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

U.N. agencies, Rotary International launch mass polio immunization campaign in Central Africa

Australian epidemics research programme to be disbanded

Scientists to present new findings from NIAID-funded research at ACAAI Annual Meeting

Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada

Stanford University scientist receives HFSP Nakasone Award for neuronal network study

SCYNEXIS receives four grants under QTDP program to develop cyclophilin inhibitors

Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications

New study sheds light on Immune Reconstitution Inflammatory Syndrome

Combination of antiviral drugs outperforms single-drug therapy in children with hepatitis C

Kylin receives $250,000 IRS award to advance pRNAi nanoparticle cancer treatment research

Researchers find text messages to HIV patients improve adherence, health outcomes in Kenya trial

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

HPV vaccination rates falter

Contraceptive, antiviral gel using bee venom wins 2010 Gates Foundation grant

World Lung Foundation report highlights prevalence of acute respiratory infections worldwide

New York Times examines HIV prevention products undergoing clinical trials

Patented cover for stethoscopes will curb hospital-acquired infections

Innovative method for in-cell gene manipulation

Researchers examine burden of HIV and sexually transmitted diseases in China

Innovation in neuroscience drug discovery - eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep